Evkeeza

What is this medication? Evkeeza is a prescription injectable medication used in combination with other lipid-lowering treatments for adults and children aged 5 years and older who have homozygous familial hypercholesterolemia. This is a rare genetic disorder that results in dangerously high levels of low-density lipoprotein cholesterol, also known as bad cholesterol, which significantly increases the risk of early heart disease. The drug belongs to a class of medications called angiopoietin-like 3 inhibitors and is delivered via an intravenous infusion administered by a healthcare professional once every four weeks.

The primary function of this medication is to block a specific protein that regulates fat metabolism in the liver. By inhibiting this protein, the drug helps the body clear low-density lipoprotein cholesterol from the blood through pathways that do not rely on traditional receptors used by other cholesterol medications. It is specifically indicated for patients with the homozygous form of familial hypercholesterolemia and is not intended for people with other causes of high cholesterol or those whose condition is not caused by this specific genetic mutation.